Literature DB >> 18508496

Roles of chemokines in renal ischemia/reperfusion injury.

Kengo Furuichi1, Takashi Wada, Shuichi Kaneko, Philip M Murphy.   

Abstract

Ischemia-reperfusion injury (IR) is a common and an important clinical cause of renal disease, such as renal transplantation, renal artery stenosis and following shock from any cause. Inflammatory reaction after IR is regulated by various kinds of mediators. Chemokines are major mediators of the inflammation, and regulate pro-inflammatory cytokine and adhesion molecule expression, and leukocyte infiltration and activation. Chemokines are the key players of inflammation, angiogenesis and fibrosis. These inflammatory processes mediated by chemokines were observed in not only experimental animal models, but also in human renal diseases with ischemic injury. A number of challenges of chemokine targeted therapy is trying to prevent the ischemic injury, and will give some beneficial effect on the injury.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18508496     DOI: 10.2741/2990

Source DB:  PubMed          Journal:  Front Biosci        ISSN: 1093-4715


  15 in total

1.  Ischaemic/reperfusion injury: Role of infliximab.

Authors:  Atul Bagul
Journal:  World J Transplant       Date:  2012-06-24

2.  The effect of thymoquinone on the renal functions following ischemia-reperfusion injury in the rat.

Authors:  Fayez T Hammad; Loay Lubbad
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-12-25

3.  Impact of kidney function and urinary protein excretion on pulmonary function in Japanese patients with chronic kidney disease.

Authors:  Yusuke Nakade; Tadashi Toyama; Kengo Furuichi; Shinji Kitajima; Noriyuki Ohkura; Akihiro Sagara; Yasuyuki Shinozaki; Akinori Hara; Kiyoki Kitagawa; Miho Shimizu; Yasunori Iwata; Hiroyasu Oe; Mikio Nagahara; Hiroshi Horita; Yoshio Sakai; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2013-12-15       Impact factor: 2.801

4.  Effects of adipose-derived mesenchymal cells on ischemia-reperfusion injury in kidney.

Authors:  Kengo Furuichi; Hidemi Shintani; Yoshio Sakai; Takahiro Ochiya; Kouji Matsushima; Shuichi Kaneko; Takashi Wada
Journal:  Clin Exp Nephrol       Date:  2012-03-08       Impact factor: 2.801

5.  Amelioration of renal ischaemia-reperfusion injury by liposomal delivery of curcumin to renal tubular epithelial and antigen-presenting cells.

Authors:  N M Rogers; M D Stephenson; A R Kitching; J D Horowitz; P T H Coates
Journal:  Br J Pharmacol       Date:  2012-05       Impact factor: 8.739

Review 6.  Pathological Mechanisms Induced by TRPM2 Ion Channels Activation in Renal Ischemia-Reperfusion Injury.

Authors:  Hossein Khanahmad; Seyedeh Mahnaz Mirbod; Farzaneh Karimi; Ebrahim Kharazinejad; Maryam Owjfard; Malihe Najaflu; Mehrsa Tavangar
Journal:  Mol Biol Rep       Date:  2022-09-14       Impact factor: 2.742

7.  Anti-inflammatory treatment strategies for ischemia/reperfusion injury in transplantation.

Authors:  Jens Lutz; Klaus Thürmel; Uwe Heemann
Journal:  J Inflamm (Lond)       Date:  2010-05-28       Impact factor: 4.981

8.  Fresh and cryopreserved, uncultured adipose tissue-derived stem and regenerative cells ameliorate ischemia-reperfusion-induced acute kidney injury.

Authors:  Zheng Feng; Joey Ting; Zeni Alfonso; Brian M Strem; John K Fraser; Joshua Rutenberg; Hai-Chien Kuo; Kai Pinkernell
Journal:  Nephrol Dial Transplant       Date:  2010-10-04       Impact factor: 5.992

Review 9.  Hematologic abnormalities following renal transplantation.

Authors:  Mark A Marinella
Journal:  Int Urol Nephrol       Date:  2009-03-20       Impact factor: 2.266

10.  Fas Ligand Has a Greater Impact than TNF-α on Apoptosis and Inflammation in Ischemic Acute Kidney Injury.

Authors:  Kengo Furuichi; Satoshi Kokubo; Akinori Hara; Ryu Imamura; Qiang Wang; Shinji Kitajima; Tadashi Toyama; Toshiya Okumura; Kouji Matsushima; Takashi Suda; Naofumi Mukaida; Shuichi Kaneko; Takashi Wada
Journal:  Nephron Extra       Date:  2012-02-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.